Literature DB >> 22812603

Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study.

Raoul Sutter1, Sarah Tschudin-Sutter, Leticia Grize, Peter Fuhr, Marc J M Bonten, Andreas F Widmer, Stephan Marsch, Stephan Rüegg.   

Abstract

PURPOSE: Status epilepticus (SE) represents a life-threatening condition, requiring pharmacologic therapy and neurointensive care. Infectious complications in SE are suspected to be frequent and worsen outcome. However, little is known about their incidence during SE and their impact on course and outcome. The aim of this study was to determine the incidence and time of onset of infections during SE, as well as their association with particular SE courses, length of hospitalization, intensive care unit (ICU) stay, and outcome.
METHODS: All consecutive ICU patients hospitalized due to SE from 2005 to 2009 at the University Hospital Basel were included. Electroencephalography (EEG) recordings and microbiologic data were extracted from two prospectively established databases. Length of SE, ICU, and hospital stay; development of refractory status epilepticus (RSE); and destinations at discharge or death were assessed by comprehensive medical chart review. KEY
FINDINGS: Of 160 patients, 23% had infections during SE. Of those, 94% were respiratory tract infections, 29% were ventilator-associated pneumonias. Patients with infections during SE had longer SE duration (p < 0.0001), longer ICU stay (p = 0.0041), higher risk of RSE (odds ratio [OR] 4.8, p = 0.0002), and higher mortality (OR 5.2, p = 0.0003) than those without infectious complications. Infections during the first 3 days after SE onset were significantly associated with longer SE duration, higher rate of RSE, and higher mortality compared to infections detected before SE. SIGNIFICANCE: Infections during SE are frequent and associated with higher mortality, prolonged ICU stay, and higher rates of RSE. Further trials are needed to provide evidence of a causative relation between infections and outcomes of SE, followed by investigations on underlying mechanisms and preventive strategies. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2012        PMID: 22812603     DOI: 10.1111/j.1528-1167.2012.03576.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

1.  Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study.

Authors:  Saskia Semmlack; Sarah Tschudin-Sutter; Andreas F Widmer; Martina Valença; Stephan Rüegg; Stephan Marsch; Raoul Sutter
Journal:  J Neurol       Date:  2016-05-03       Impact factor: 4.849

2.  Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort Study.

Authors:  Raoul Sutter; Gian Marco De Marchis; Saskia Semmlack; Peter Fuhr; Stephan Rüegg; Stephan Marsch; Wendy C Ziai; Peter W Kaplan
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

Review 3.  Healthcare-Associated Infections in the Neurocritical Care Unit.

Authors:  Katharina M Busl
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-27       Impact factor: 5.081

4.  Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.

Authors:  Raoul Sutter; Stephan Marsch; Peter Fuhr; Peter W Kaplan; Stephan Rüegg
Journal:  Neurology       Date:  2013-12-06       Impact factor: 9.910

5.  Emergency First-Line Anti-Seizure Medication for Seizures and Status Epilepticus: What is Going Wrong, Doctor?

Authors:  Raoul Sutter
Journal:  CNS Drugs       Date:  2018-10       Impact factor: 5.749

Review 6.  Outcome predictors for status epilepticus--what really counts.

Authors:  Raoul Sutter; Peter W Kaplan; Stephan Rüegg
Journal:  Nat Rev Neurol       Date:  2013-08-06       Impact factor: 42.937

Review 7.  Systemic Complications Following Status Epilepticus.

Authors:  Maximiliano A Hawkes; Sara E Hocker
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-07       Impact factor: 5.081

8.  Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score.

Authors:  Qiong Gao; Tang-peng Ou-Yang; Xiao-long Sun; Feng Yang; Chen Wu; Tao Kang; Xiao-gang Kang; Wen Jiang
Journal:  Crit Care       Date:  2016-02-25       Impact factor: 9.097

9.  Delays and Factors Related to Cessation of Generalized Convulsive Status Epilepticus.

Authors:  Leena Kämppi; Jaakko Ritvanen; Harri Mustonen; Seppo Soinila
Journal:  Epilepsy Res Treat       Date:  2015-08-10

10.  Procalcitonin and mortality in status epilepticus: an observational cohort study.

Authors:  Raoul Sutter; Martina Valença; Sarah Tschudin-Sutter; Stephan Rüegg; Stephan Marsch
Journal:  Crit Care       Date:  2015-10-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.